Get informed when a big investor buys or sells
+ FollowOvervalued by 44.1% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $575.90 Million |
|---|---|
| Enterprise Value | $459.10 Million |
| Earnings per Share | $0.06 |
| Beta | 1.2 |
| Outstanding Shares | 300,851,252 |
| P/E Ratio | 48.05 |
|---|---|
| PEG | -192.54 |
| Price to Sales | 1.93 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.14 |
| Enterprise Value to EBIT | 13.3 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.18 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Nanosonics Limited, along with its subsidiaries, functions as a global infection prevention enterprise with operations in Australia and beyond. The company focuses on the production and distribution of its trophon ultrasound probe disinf...